Two new minor constituents, musinisins A (1) and B (2), together with five known compounds (3-7), were isolated from the aerial parts of Munronia sinica. Their structures were established by means of spectroscopic methods and the absolute stereochemistry of 1 was determined by single crystal X-ray experiment. Compound 4 showed antiangiogenic activity evaluated by a zebrafish model and apoptosis-inducing effect on A549 lung cancer cells.
Introduction
The genus of Munronia (Meliaceae) is composed of about 15 species in the world, and 8 species of them were distributed in China. 1 Up to now, some phytochemical studies have been reported on M. delavayi [2] [3] [4] [5] and M. henryi [6] [7] [8] [9] , and tetranortriterpenoids and triterpenoids are their main components. Especially, tetranortriterpenoids exhibit chemical defensive function in nature, such as antibacterium, antifungal, 2 and antifeeding 8 activities. M. sinica Diels grows in Jinfoshan of Sichuan, which is low subshrubs and an endemic species of China. To the date, no chemical research has been published about this species. In this paper, we reported the isolation and structure elucidation of two new compounds, musinisins A (1) and B (2), together with five known compounds, including glucoacetosyringone (3), 10 6,7-bis(acetyloxy)-4,4,8-trimethyl-3-oxo-(5α,6α,7α,13α,17α,20ξ)-carda-1,14-dienolide (4), 11 cannabiside D (5), 12 corchoionoside C (6), 13 (+)-3-oxo-α-ionyl glucoside (7). 14 Compounds 1-7 were tested for their antiangiogenic activities using a zebrafish model and the antiproliferative activities using A549 lung cancer cells.
Results and Discussion
A 70% aqueous acetone extract prepared from the leaves and stems of M. sinica was partitioned between EtOAc and H 2 O. The EtOAc layer was subjected repeatedly to column chromatography on silica gel, Sephadex LH-20, and RP-18, to afford compounds 1-7. Their structures were shown in Figure  1 , and 1 H and 13 C NMR spectroscopic data were listed in Tables 1 and 2 . The anomeric center of the sugar moiety was determined to be -configuration from the large 3 J H1-H2 value (J = 7.8 Hz). Furthermore, we get a suitable crystal and the X-ray experiment was conducted using an anomalous dispersion with copper radiation (Figure 3 ), which not only determined the hexose to be D-glucose, but also established the absolute stereochemistry of 1. In combination with IUPAC sequence rule, 15 the configuration of C-3 and C-4 were deduced as R and S, respectively. Thus, the structure of 1 was established as (3R,4S)-3-isopropyl-4-hydroxypentanoic acid 4-O-β-D-glucopyranoside and given the name of musinisin A. The plausible biogenetic pathway of 1, starting from, 3-isopropyl-4-methylcyclohexene was also discussed (Scheme 1).
Compound 2 was isolated as yellow powder with [α] 19.9 D -54.86 (c 0.14, MeOH). The molecular formula, C 16 (Table 2) showed signals for two methoxyl groups. Comparison of the 1D and 2D NMR data of 2 with those of known compound glucoacetosyringone (3) 10 revealed that compound 2 was structurally similar to 3. The differences were resulted from the appearance of an oxygenated methine signal ( C 68.2, CH;  H 4.6, m), and the lack of a carbonyl signal in 2. This indicated that the carbonyl group at C-7 in 3 was replaced by an oxygenated methine group in 2, which was confirmed by the HMBC correlations of H-2 ( H 6.62), H-6 ( H 6.62) and Me-8 ( H was determined to be -configuration from the large 3 J H1-H2 value (J = 7.3 Hz). As the aglycone showed a negative optical rotation value that was opposite to that of (1R)-1-phenyl-1-propanol, 16 the absolute configuration at C-7 of 2 was suggested to be S. Thus, the structure of 2 was established and given the trivial name musinisin B.
The antiangiogenic activities of compounds 1, 2, 4, 5 and 7 were evaluated using a zebrafish model, in terms of the inhibition on the growth of intersegmental vessels, with PTK787 as positive control (IC 50 0.15 g/mL). 17 The results showed that intersegmental vessels of embryos treated with 4 was significantly less than that of the control (0.1% DMSO in sterile salt water). The inhibition ratio of 4 was 58.7% at a concentration of 40 g/mL (Table 3 ). The antiproliferative activities of compounds 1-7 were evaluated using A549 lung cancer cells by MTT assay. 18 The results indicated that compounds 1, 2, 4 and 7 showed a certain extent antiproliferative activities (Table 4) . From the photos of acridine orange staining, compound 4 showed obvious effect of inducing apoptosis of A549 lung cancer cells (Figure 4 ).
Experimental Section
General Experimental Procedures. Melting point was obtained on an XRC-1 micro melting point apparatus and is uncorrected. Optical rotations were measured with a Jasco P-1020 polarimeter. UV spectra were obtained using a Shimadzu UV-2401A spectrophotometer. A Bruker Tenor 27 spectrophotometer was used for scanning IR spectroscopy with KBr pellets. 1D and 2D NMR spectra were recorded on Bruker DRX-500 spectrometers. Unless otherwise specified, chemical shifts () were expressed in ppm with reference to the solvent signals. Mass spectra were performed on an API QSTAR Pulsar i spectrometer. Column chromatography was performed with silica gel (200-300 mesh, Qingdao Marine Chemical, Inc., Qingdao, China). Fractions were monitored by TLC and spots were visualized by heating silica gel plates sprayed with 10% H 2 SO 4 in EtOH. Antiangiogenesis Bioassay. Stock solutions (10 mg/mL) of all samples were prepared by dissolving the test compounds in 100% DMSO. These solutions were diluted in sterile salt water (5 mM NaCl, 0.17 mM KCl, 0.4 mM CaCl 2 , and 0.16 mM MgSO 4 ) to obtain solutions with the test compounds dissolved in 0.1% DMSO. These solutions were aliquot into 96-well plates, and embryos at 24 hpf (hours post fertilization) were also transferred randomly into the above wells. After 24h of treatment, the intersegmental vessels of embryos were visualized with green fluorescent protein labeling and endogenous alkaline phosphatase staining. The antiangiogenic activities of compounds were calculated from the inhibition ratio of angiogenesis. PTK787 was used as the positive control.
Antiproliferative Bioassay. A549 lung cancer cells were cultured in RPMI 1640 medium at 37 o C with 5% CO 2 and 95% air, supplemented with 10% (v/v) bovine calf serum and 80 U/ml penicillin/streptomycin. The cells were seeded onto 96-well plates and treated with compounds at 3, 10, 30 and 100 g/mL for 48h, respectively. Cell viability was determined by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium) assay. The light absorption was measured at 570 nm using Spectra MAX 190 microplate spectrophotometer (GMI Co., USA). Inhibition rate was calculated by the formula:
Inhibition (%) = 100% -(OD treatment -OD blank )/(OD control -OD blank ) × 100%
The cells were incubated with compounds (100 g/mL) for 48 h, and stained with 0.1 mg/ml of acridine orange (AO) at room temperature for 5 min. Then the cells were observed and photographed using the fluorescent stereo microscope (Olympus, Japan).
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